Processa Pharmaceuticals, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
PCSA on Nasdaq
Industry
Pharmaceutical Preparations
Location
7380 Coca Cola Drive, Suite 106, Hanover, MD

Insiders trading volume in the past year

Processa Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David Young Pres. Research & Development, Director $285K +$102K +55.9% Apr 5, 2024
Sian Bigora Chief Development Officer $96.6K Apr 5, 2024
Justin W. Yorke Director $94.2K +$21.5K +29.7% Sep 3, 2024
Patrick Lin Chief Business - Strategy Off $92.3K +$9.53K +11.5% Apr 5, 2024
Wendy Guy Chief Administrative Officer $77.1K Apr 5, 2024
Russell Skibsted Chief Financial Officer $68.7K Jul 16, 2024
James H. Stanker Chief Financial Officer $61.6K Apr 5, 2024
George Ng Chief Executive Officer, Director $54K +$27K +100% Jan 30, 2024
Michael Floyd Chief Operating Officer $51.6K Feb 9, 2023
Virgil Thompson Director $42.2K Jun 27, 2023
Geraldine Pannu Director $17.3K Sep 3, 2024
Khalid Islam Director Mar 31, 2022
Khoso Baluch Director Sep 3, 2024
James Neal Director Sep 3, 2024

Recent Insider Transactions by Companies or Individuals for Processa Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.